Serum Institute develops first indigenous vaccine against pneumonia; to be launched next week

India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37KFQUQ
via IFTTT